Narongrit Sritana MSc1, Chantragan Srisomsap PhD2, Daranee Chokchaichamnankit MSc2, Jisnuson Svasti PhD2,3, Orathai Promsuwicha MSc4, Chirayu Auewarakul MD, PhD4,5
Affiliation : 1 Molecular Biology and Genomic Research Laboratory, Division of Research and International Relations, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand 2 Laboratory of Biochemistry, Chulabhorn Research Institute, Bangkok, Thailand 3 Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok, Thailand 4 Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand 5 Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
Background : Several nonrandom chromosomal abnormalities have been identified in acute myeloid leukemia [AML] and are
strong determinants of prognostic outcome and therapeutic response. Because clinical outcomes of AML patients with
cytogenetic aberrations differ considerably, we hypothesized that their proteomes may also differ, particularly in their
expression patterns and protein interaction pathways.
Objective : To study the protein profiling that is related to different karyotypes of AML patients.
Materials and Methods : We performed proteomic analysis using 20 AML samples with various cytogenetic abnormalities
including t(8;21) (n = 4), t(15;17) (n = 3), inv(16) (n = 4), trisomy 8 (n = 3), trisomy 11 (n = 3) and trisomy 21 (n = 3).
Proteins from bone marrow cells were separated by two-dimensional gel electrophoresis and the protein profiles were
compared among the samples.
Results : Favorable karyotypes, such as t(8;21), t(15;17) and inv(16), showed similar protein profiles within their own
groups but differed from all other subgroups, whereas the trisomy group had similar protein profiles only within the same
French-American-British morphological classification. As previously reported, some identified proteins by LC/MS/MS
spectrometer, including transgelin-2, were also expressed in leukemic cells from patients or leukemia cell lines.
Conclusion : Unique proteomic patterns were identified in some AML subgroups. AML patients may be further sub-
classified using protein profiles generated by this approach in combination with the current standard diagnostic methods.
Keywords : proteomics, leukemia, acute myeloid leukemia, classification, diagnostic methods
JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND
4th Floor, Royal Golden Jubilee Building,
2 Soi Soonvijai, New Petchburi road,
Bangkok 10310, Thailand.
Phone: 0-2716-6102, 0-2716-6962
Fax: 0-2314-6305
Email: editor@jmatonline.com
» Online Submissions » Author Guidelines » Copyright Notice » Privacy Statement
» Journal Sponsorship » Site Map » About this Publishing System
© MEDICAL ASSOCIATION OF THAILAND. All Rights Reserved. The content of this site is intended for health professionals.